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Rapid Method for Determination of Antimicrobial

Susceptibilities Pattern of Urinary Bacteria 
S
A quick method has been developed for detecting 
bacterial sensitivity to antimicrobial agents by 
measuring the level of adenosine triphosphate (ATP) 
remaining in the bacteria. The amount of ATP in a 
sample is determined by measuring the light emitted 
during the reaction of the sample with a mixture of 
luciferase and luciferin. This method enables data to 
be obtained within 2-1/2 hours after treatment with 
an antibiotic, as compared to the 18 hours required 
using conventional agar diffusion, broth dilution, and 
agar dilution techniques. 
A bacterial sample is cultured and assayed for its 
adenosine triphosphate content by first destroying all 
nonbacterial ATP in solution. The bacterial cells are 
ruptured to release ATP; the remaining ATP is 
measured via bioluminescence. After the initial assay, 
the culture is subjected to an antibiotic for a growth 
period and then is remeasured for bacterial ATP, 
using the same luciferase-luciferin technique. Data 
obtained from each assay, before and after exposure 
of the bacterium to the antibiotic, are then used to 
calculate an ATP index, which is a measure of 
bacterial sensitivity to a specific antibiotic. 
When adapting this technique to detect bacteria in 
urine, a method first had to be developed to separate 
nonbacterial sources of ATP from the bacteria. 
Typical sources include free soluble ATP and the ATP 
present in red and white blood cells. To separate, the 
urine sample is treated with a nonionic detergent 
which ruptures any red and white blood cells present, 
releasing ATP into solution in a freely soluble form. 
The free nonbacterial ATP is hydrolyzed with an ATP 
hydrolyzing enzyme, or ATPase; the ATPase then is 
denatured via a chemical or heat.
Bacterial ATP is released by rupturing the bacterial 
cells with ar acid. The solution is neutralized; the pH 
and ionic strength of the sample are adjusted by a 
buffer for optimum luciferase activity. The solution is 
then treated with the luciferase-luciferin mixture. If 
ATP is present, light is emitted from the biolumines-
cent reaction and is detected and recorded. 
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